TITAN PHARMACEUTICALS INC

Profile

Company Names

TITAN PHARMACEUTICALS INC

Addresses

400 OYSTER POINT BLVD, SUITE 505, SAN FRANCISCO, CA 94080

Phone Numbers

6502444990

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$15,494,931.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2022-02-04 
$1,520,669.00 
$7,019,570.00 
$5,498,901.00 
 
3
2021-01-20 
$9,673,750.00 
$9,673,750.00 
$0.00 
 
2
2020-01-09 
$2,175,000.00 
$2,175,000.00 
$0.00 
 
1
2019-08-09 
$2,125,512.00 
$2,125,512.00 
$0.00 
 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOSEPH 
A. 
AKERS 
DIRECTOR
KATHERINE 
 
BEEBE 
EXECUTIVE OFFICER
SUNIL 
 
BHONSLE 
EXECUTIVE OFFICER, DIRECTOR
KATHERINE 
 
DEVARNEY 
EXECUTIVE OFFICER, DIRECTOR
KATHERINE 
BEEBE 
DEVARNEY 
EXECUTIVE OFFICER, DIRECTOR
DANE 
 
HALLBERG 
EXECUTIVE OFFICER
RAJINDER 
A. 
KUMAR 
DIRECTOR
M. 
DAVID 
MCFARLANE 
DIRECTOR
JAMES 
R. 
MCNAB, JR. 
DIRECTOR
MARC 
 
RUBIN 
EXECUTIVE OFFICER, DIRECTOR
SCOTT 
A. 
SMITH 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
 
2022-02-04 
D
PHARMACEUTICALS 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
 
2021-01-20 
D
PHARMACEUTICALS 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
 
2020-01-09 
D
PHARMACEUTICALS 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
 
2019-08-09 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
MAXIM GROUP LLC